Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, is sharing timely public health insights from Dr. Jonathan Temte, Professor of Family Medicine and Community Health at the University of Wisconsin-Madison.
In this 50th episode of QuidelOrtho Science Bytes, Dr. Temte outlines the seasonal challenges posed by influenza, RSV, COVID-19 and vaccine-preventable diseases such as measles and whooping cough. He emphasizes that early detection through rapid diagnostic testing, combined with data-driven surveillance and practical prevention measures, can help keep students healthy and in school.
Key points from Dr. Temte's discussion include:
- Early detection supports better outcomes: Rapid diagnostics enable targeted treatment and help reduce unnecessary antibiotic use
- Absenteeism data can signal outbreaks: Illness-related absences often predict community spread before it peaks
- Prevention protects communities: Preventive practices reduce transmission in schools and at home
This episode reflects QuidelOrtho's commitment to equipping healthcare providers and the public with timely, actionable information. By highlighting expert insights and practical solutions, QuidelOrtho aims to reduce illness spread and safeguard community health.
The QuidelOrtho Science Bytes podcast is available on major streaming platforms and at: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day.
By offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact: Juliet Cunningham Vice President, Investor Relations | Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications |
View original content to download multimedia:https://www.prnewswire.com/news-releases/science-bytes-podcast-explores-how-diagnostics-can-help-protect-students-and-communities-302535145.html
SOURCE QuidelOrtho Corporation
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Nachrichten zu Quidel Corp.
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Quidel Corp.
Datum | Rating | Analyst | |
---|---|---|---|
22.01.2018 | Quidel Overweight | Barclays Capital | |
18.07.2017 | Quidel Buy | Canaccord Adams | |
25.04.2017 | Quidel Hold | Canaccord Adams | |
08.01.2016 | Quidel Buy | Canaccord Adams | |
02.09.2015 | Quidel Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
22.01.2018 | Quidel Overweight | Barclays Capital | |
18.07.2017 | Quidel Buy | Canaccord Adams | |
08.01.2016 | Quidel Buy | Canaccord Adams | |
02.09.2015 | Quidel Overweight | Barclays Capital | |
04.01.2011 | Quidel outperform | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2017 | Quidel Hold | Canaccord Adams | |
03.03.2011 | Quidel neutral | Wedbush Morgan Securities Inc. | |
30.09.2009 | Quidel market perform | William Blair |
Datum | Rating | Analyst | |
---|---|---|---|
29.08.2006 | Update Quidel Corp.: Strong Sell | Matrix Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quidel Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen